Buy Hold Sell, by Livewire Markets

In the wake of the budget and the proposed CGT changes, there has been plenty of spirited debate about the future of growth investing in our great country. And rightly so. 

But let's get real. Whatever we might think about the changes, Aussies will still create and invest in great growth businesses. It's in our blood. 

No tax change is going to completely crush home-grown innovation - the very innovation which brought us the Coolgardie cooler, the Hills Hoist, the Cochlear implant, and WiFi. Oh, and Tim Tams... mustn't forget the Tim Tams. 

Typically, these great growth stories are born from the small-cap end of the market, so in this episode, Livewire's Chris Conway is joined by Oscar Oberg from Wilson Asset Management and Alex Shevelev from Forager Funds Management, who each bring three stocks they believe have big potential. 

That’s right, it’s going to be wall-to-wall buys for this episode so strap in, and let's go!

This episode was filmed on Wednesday, 20th May 2026.

While much of the market has been nursing its wounds in 2026, the financial sector has been quietly holding up. But nothing stays comfortable forever. 

With a fresh rate hike hitting the market and bank valuations looking increasingly stretched, one of our guests this week puts it best - the banks are running on Wile E. Coyote physics. Off the cliff, still running - just haven't looked down yet.

So where does the smart money go from here? Because if the bank trade is getting crowded, the case for rotating into other parts of the sector, insurance in particular, is building fast. Higher rates, a more benign catastrophe environment, and valuations that haven't re-rated yet. It's a combination that's hard to ignore.

To work through it all, I'm joined by Julia Weng from Paradice Investment Management and Hamish FitzSimons from AllianceBernstein. Between them, they'll be analysing five stocks in the sector and sharing one high conviction pick each for where they see the real value.

Inflation, shifting rates, and volatile oil prices have served up a "vicious cocktail" for investors. While many of 2025’s high-flyers have come back to earth, the dynamic small and mid-cap market remains a breeding ground for opportunity.

In this episode of Buy Hold Sell, Chris Prunty (QVG Capital) and Chris Stott (1851 Capital) go head-to-head on five stocks from the growth engine of the ASX. 

They run the ruler over three "fallen angels" ripe for a rebound, two names testing 52-week highs, and reveal the "steady compounders" they’re backing for the year ahead.

Plus, we break down the must-know takeaways from the Macquarie Conference.

For years, the ASX healthcare sector was the picture of health itself - a compounding growth story that investors treated as a set-and-forget holding. Then came a brutal twelve months. The sector has shed nearly 40%, with former darlings and long-standing heavyweights hitting lows not seen in a decade. The causes aren't simple, and perhaps most disorienting is the ‘defensiveness’ that investors paid a premium for has simply stopped working. As one of our guests in this week's episode says, to quote The Castle - "The vibe is off." To work through the prognosis, Livewire's Anna Dadic is joined by Julia Weng of Paradice Investment Management and Hamish FitzSimons of AllianceBernstein. In this episode, five sector stocks are put under the microscope. Our guests unpack the sell-off, make the case for where the stock-picking opportunities lie, and as always, share a high-conviction pick of their own. This episode was filmed Wednesday 6th May 2026.

This episode was filmed Wednesday 22nd April, 2026.

Human nature pulls us toward the bargain, the beaten-up, the overlooked. Who doesn't love a sale? Buying a stock that's already doubled feels wrong. Dangerous, even. But some of the best money made has come from backing winners that just kept winning.

The first half of 2026 has been a wild ride. The broader market has been middling at best. But beneath the surface, a handful of small and mid-cap stocks have defied the macro gloom entirely - Codan and Cuscal are just two names that have more than doubled in the past year, leaving investors on the sidelines wondering whether they've missed the boat altogether. 

So have they? Or is the rally just beginning?

To help make sense of the top performers of the year so far, Anna Dadic is joined by two fund managers who know this space better than most. Lucas Goode from IML and Ben Rundle from Hayborough Investment Partners. Between them, they run the ruler over five of the ASX's biggest high flyers of the year so far and we ask the question every investor is thinking: is there still fuel in the tank to keep flying?

Let's find out!